Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565 Japan; Department of Anesthesiology, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.
Auton Neurosci. 2013 Oct;177(2):123-8. doi: 10.1016/j.autneu.2013.03.004. Epub 2013 Apr 3.
We applied microdialysis technique to the left adrenal medulla of anesthetized rats and examined the effects of intravenous Mg(2+) infusion on presynaptic acetylcholine (ACh) release and postsynaptic catecholamine release induced by electrical stimulation of splanchnic nerves. The dialysis probes were perfused with Ringer's solution containing neostigmine. Low-dose MgSO4 (25 μmol/kg/min for 30 min i.v.) increased mean plasma Mg(2+) concentration to 2.5mM; the administration suppressed norepinephrine (NE) release by approximately 30% and epinephrine (Epi) release by approximately 20%, but did not affect ACh release. High-dose MgSO4 (50 μmol/kg/min for 30 min i.v.) increased mean plasma Mg(2+) concentration to 3.8mM; the administration suppressed ACh release by approximately 25%, NE release by approximately 60% and Epi release by approximately 45%. Administration of Na2SO4 (50 μmol/kg/min for 30 min i.v.) did not change the release of ACh, NE or Epi. Local administration of nifedipine (200 μM) suppressed NE release by approximately 40% and Epi release by approximately 30%, but did not affect ACh release. In the presence of nifedipine, low-dose MgSO4 did not suppress the release of ACh, or further suppress NE or Epi compared to nifedipine alone, but high-dose MgSO4 suppressed ACh release by approximately 25% and further suppressed NE release by approximately 60% and Epi release by approximately 50% compared to nifedipine alone. In conclusion, intravenous administration of Mg(2+) inhibits both presynaptic ACh release and postsynaptic catecholamine release in the adrenal medulla, but L-type Ca(2+) channel-controlled catecholamine release may be more sensitive to Mg(2+) than non-L-type Ca(2+) channel-controlled ACh release.
我们应用微透析技术于麻醉大鼠的左肾上腺髓质,观察静脉内镁(Mg)输注对内脏神经电刺激诱导的前突触乙酰胆碱(ACh)释放和后突触儿茶酚胺释放的影响。透析探针用含新斯的明的林格氏液灌流。小剂量硫酸镁(25 μmol/kg/min 静脉内输注 30 分钟)使平均血浆 Mg(2+)浓度增加到 2.5mM;该给药抑制去甲肾上腺素(NE)释放约 30%,肾上腺素(Epi)释放约 20%,但不影响 ACh 释放。大剂量硫酸镁(50 μmol/kg/min 静脉内输注 30 分钟)使平均血浆 Mg(2+)浓度增加到 3.8mM;该给药抑制 ACh 释放约 25%,NE 释放约 60%,Epi 释放约 45%。静脉内给予硫酸钠(50 μmol/kg/min 静脉内输注 30 分钟)不改变 ACh、NE 或 Epi 的释放。局部给予硝苯地平(200 μM)抑制 NE 释放约 40%,Epi 释放约 30%,但不影响 ACh 释放。在硝苯地平存在的情况下,小剂量硫酸镁与单独给予硝苯地平相比,不抑制 ACh 释放,也不进一步抑制 NE 或 Epi 释放,但大剂量硫酸镁抑制 ACh 释放约 25%,进一步抑制 NE 释放约 60%,Epi 释放约 50%,与单独给予硝苯地平相比。总之,静脉内给予 Mg(2+)抑制肾上腺髓质中的前突触 ACh 释放和后突触儿茶酚胺释放,但 L 型 Ca(2+)通道控制的儿茶酚胺释放可能比非 L 型 Ca(2+)通道控制的 ACh 释放对 Mg(2+)更敏感。